Listen to this article
We prefer simple flat-rate unrestricted subscriptions — we’ll work on your terms, and with your favorite subscription contract template, to find a solution that fits.
If your colleagues would like to test the platform, we can take one of a few approaches:
- A short trial
- Quarterly company-wide access
- A small number of annual subscriptions for selected users to test before making any additional commitments.
Contact us for more…Copyright © DrugPatentWatch. Originally published at Thinking of signing your company up for DrugPatentWatch?